- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 279/12 - 1,4-ThiazinesHydrogenated 1,4-thiazines not condensed with other rings
Patent holdings for IPC class C07D 279/12
Total number of patents in this class: 166
10-year publication summary
|
8
|
8
|
13
|
15
|
5
|
9
|
9
|
11
|
7
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Global Blood Therapeutics, Inc. | 181 |
10 |
| Amgen Inc. | 4286 |
6 |
| Cassava Science, Inc. | 13 |
5 |
| Merck Sharp & Dohme LLC | 3745 |
5 |
| Imago Biosciences, Inc. | 38 |
4 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 179 |
4 |
| The University of Melbourne | 558 |
4 |
| The University of Toledo | 430 |
4 |
| Novartis AG | 10500 |
3 |
| Janssen Pharmaceutica N.V. | 3341 |
3 |
| Pharmaxis Ltd | 34 |
3 |
| Washington State University | 493 |
3 |
| Lockheed Martin Energy, LLC | 147 |
3 |
| Aligos Therapeutics, Inc. | 162 |
3 |
| Atux Iskay LLC | 9 |
3 |
| Orsobio, Inc. | 14 |
3 |
| Merck Sharp & Dohme Corp. | 2187 |
2 |
| Syngenta Crop Protection AG | 6321 |
2 |
| FUJIFILM Corporation | 30012 |
2 |
| Sumitomo Chemical Company, Limited | 9040 |
2 |
| Other owners | 92 |